期刊
NANOMEDICINE
卷 6, 期 9, 页码 1529-1544出版社
FUTURE MEDICINE LTD
DOI: 10.2217/NNM.11.47
关键词
biocompatibility; biodistribution; dimercaptosuccinic acid; DMSA; magnetic nanoparticle; nanotoxicity n nonhuman primate
资金
- MCT
- FINEP
- CNPq
- INCT Nanobiotechnology
- FINATEC
- FAP-DF
- CAPES
Aim: This work represents the first reported investigation on the effects of magnetic nanoparticles (MNPs) in nonhuman primates. Biodistribution, biocompatibility and nanotoxicity of maghemite nanoparticles stabilized with dimercaptosuccinic acid (DMSA) were accessed. Materials & Methods: A control animal was used and three other animals were intravenously injected with DMSA-MNPs and euthanized 12 h, 30 and 90 days following administration. Extracted organs were processed by histological techniques. An additional animal was used to collect blood samples to complementarily assess biocompatibility 12 h, 7, 15, 30, 60 and 90 days after DMSA-MNP injection. Results: DMSA-MNPs were preferentially addressed to the lungs, liver and kidneys. Hematological and serum biochemical results corroborated histological findings, supporting DMSA-MNP biocompatibility while preserving both hepatic and renal normal activity. Conclusion: DMSA-MNPs were preferentially distributed to the lung, liver and kidneys. Furthermore, DMSA-MNPs were considered biocompatible, supporting their application as a promising nanomaterial platform for future biomedical use.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据